Mechanobiological control of cytotoxic T cell-mediated anti-tumour responses

MRC · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

March 02, 2028
Response Due
Active
Status

Opportunity Overview

Cytotoxic T cells are a critical part of our immune system. They are the white blood cells responsible for detecting and destroying cancer cells. For them to function properly they first need to migrate into the cancer tissue. They then tightly attach to their targets before killing them. Tumour tissues, however, tend to be much stiffer than healthy tissue and it has previously been shown that T cells can struggle to enter stiff tumours. This increase in stiffness is due to several reasons, including the accumulation of fluids and the growth of the cancer cells themselves, which leads to fluid and mechanical stress.

Our research focuses on cytotoxic T cells and we plan to determine how fluid and mechanical stress can affect their ability to attach to and destroy cancer cells. We suspect that one critical factor is that they need to be able to rapidly change both their shape and their size. This allows them to migrate through narrow gaps in tissues and to attach to target cells to destroy them. However, if tumours are particularly stiff, such as is the case for breast cancer, we suspect that the external forces acting on T cells may be too big for them to overcome and their ability to navigate through the tumour and kill may be restricted. Of particular interest thereby is a protein called WNK1, which previously has mostly been studied for its role in salt reabsorption in the kidney. New results from our lab, show that WNK1 also has vital roles in T cells and is required for them to change their size and shape.

In this project, we will investigate how tumours stiffness affects T cell shape and size regulation and thereby their ability to destroy cancer cells, and how the two major components of tumour stiffness contribute to these processes. As T cells lacking WNK1 are very small and unable to change their shape, they will serve as a model to study what the impact of size and shape regulation is on T cell function.

The knowledge gained in this study will create...

This is one of 1,831 active United Kingdom Research Development opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryResearch Development
PublishedMarch 03, 2025
Procurement stageActive solicitation
Response dueMarch 02, 2028
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 12, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Related Opportunities in United Kingdom

Rotation year
Title of project: Evaluation of the quantitative accuracy and radiation dosimetry of an advanced pre-clinical multipinhole SPECT/CT theranostic imag
Discerning MCT1s role in chromatin remodelling and metabolomics changes in cancer progression
Leveraging real world data to characterise the long term impact of COVID-19
Bacterial antibiotic resistance: structure, mechanism and inhibition of ABC transporters responsible for drug efflux and cell wall biogenesis.
Characterising the role of TEX12 in centrosome and cilia development
Allogeneic Chondroprogenitor Therapy (Phase II) (ACT2)
Iron and immunity

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.